Given its crucial role in lipid metabolism, ATP Citrate Lyase is considered a promising therapeutic target. Inhibitors of ACLY are being developed and tested for their potential to treat metabolic diseases and certain cancers. By reducing the activity of this enzyme, it may be possible to decrease lipid synthesis and slow down the progression of these diseases.
